Co-Delivery Nanosystems for Cancer Treatment: A Review

Reza Baradaran Eftekhari1, Niloufar Maghsoudnia1, Shabnam Samimi1

  • 1Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Insights

Cancer treatment faces challenges due to disease complexity. Co-delivery systems combining multiple therapies, like chemotherapy, gene therapy, and plant-derived compounds, offer enhanced efficacy over single-agent approaches.

Area of Science:

  • Oncology
  • Nanotechnology
  • Pharmacology

Background:

  • Cancer's biological complexity necessitates advanced therapeutic strategies.
  • Single-drug delivery systems often show insufficient efficacy in suppressing tumor growth.
  • Current delivery systems have inherent limitations, driving the need for innovative approaches.

Purpose of the Study:

  • To review various strategies for co-delivery of therapeutic agents in cancer treatment.
  • To explore the synergistic potential of combining different therapeutic modalities.
  • To highlight recent advancements in co-delivery systems for oncology.

Main Methods:

  • Categorization of co-delivery strategies into conventional chemotherapeutics, gene-based molecules, and plant-derived materials.
  • Review of recent research examples for each category.
  • Analysis of opportunities and restrictions of different co-delivery systems.

Main Results:

  • Co-delivery systems can enhance therapeutic response and achieve synergistic effects.
  • Combined approaches show improved cancer growth suppression compared to single-agent strategies.
  • Diverse therapeutic agents, including chemotherapy, gene therapy, and natural compounds, are being co-delivered.

Conclusions:

  • Co-delivery represents a promising strategy to overcome the limitations of single-agent cancer therapies.
  • Synergistic combinations of therapeutic agents are crucial for improving treatment outcomes.
  • Further research into advanced co-delivery systems is essential for effective cancer treatment.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Review and Preview01:10

Review and Preview

In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
8.3K
Review and Preview01:13

Review and Preview

Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
11.0K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
856
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
976